论文信息 - 450O Initial monotherapy results of a phase I first-in-human study of ULK1/2 inhibitor DCC-3116 alone and in combination with MAPK pathway inhibition - 字舞流文

450O Initial monotherapy results of a phase I first-in-human study of ULK1/2 inhibitor DCC-3116 alone and in combination with MAPK pathway inhibition

A. Tolcher | K. Sprott | R. Ruiz-Soto | F. Reu | M. Sherman | C. Weekes | C. Psoinos | D. Hong | D. Brennan | L. Viswanathan | R. Amaravadi | A. Vandross